Clinical Trials in New York State

Showing 10441-10460 of 17,167 trials

Patient Reported Outcome Instruments in Sarcoidosis

NCT04342403

Evaluate change of quality of life of sarcoiodosis patients over a six months using various quality of life instruments including a monthly smart phone app.

Sarcoidosis

University of Cincinnati350 participantsStarted Apr 2017

Albany, New York, United States • Cincinnati, Ohio, United States • Cleveland, Ohio, United States

TERMINATEDPhase 295 miles

Study Of Two Non-Myeloablative Stem Cell Transplant Strategies For Low-Grade Lymphoma And CLL

NCT00041288

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Peripheral stem cell transplantation may be able to replace immune cells that were destroyed by chemotherapy or radiation therapy. Sometimes the transplanted cells are rejected by the body's normal tissues. Cyclosporine, mycophenolate mofetil, methotrexate, and tacrolimus may prevent this from happening. PURPOSE: Randomized phase II trial to compare the effectiveness of fludarabine plus total-body irradiation with that of combination chemotherapy followed by donor peripheral stem cell transplantation in treating patients who have relapsed non-Hodgkin's lymphoma or chronic lymphocytic leukemia.

LeukemiaLymphoma

University of Texas Southwestern Medical Center10 participantsStarted Oct 2001

Denver, Colorado, United States • Newark, Delaware, United States • Orlando, Florida, United States +20 more locations

Patient Reported Outcome Instruments in Sarcoidosis

Study Of Two Non-Myeloablative Stem Cell Transplant Strategies For Low-Grade Lymphoma And CLL

Find Trials by Condition in New York State

ESSENCE Study: Efficacy and Safety of SD-101 Cream in Participants With Epidermolysis Bullosa

Deceased Donor Biomarkers and Recipient Outcomes

Comparative and Pragmatic Study of Golimumab Intravenous (IV) (Simponi Aria) Versus Infliximab (Remicade) in Rheumatoid Arthritis

Clinical Study of the BARD® COVERA™ Arteriovenous (AV) Stent Graft in AV Graft Patients (AVeVA)

USS Virginia Closed-Loop for Overnight Control in Type 1 Diabetes

LEVANT 2 Continuation Registry of the Lutonix® Drug Coated Balloon (DCB)

Moxetumomab Pasudotox for Advanced Hairy Cell Leukemia

Study of Alirocumab (REGN727/SAR236553) added-on to Rosuvastatin Versus Other Lipid Modifying Treatments (LMT) (ODYSSEY OPTIONS II)

Evaluation of a New Critical Pathway for Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI)

N-acetylcysteine Plus Naltrexone for the Treatment of Alcohol Dependence

Proton Radiotherapy for Stage I, IIA, and IIB Seminoma

Combination Chemotherapy in Hodgkin's Disease or Non-Hodgkin's Lymphoma Not Responding to Previous Treatment

Intervention for Battered Sheltered Women With Substance Use Randomized Trial

Phase 1 Dexlansoprazole Delayed-Release Capsules for Acid-Related Disorders in Infants Aged 1 to 11 Months

Flavopiridol in Treating Patients With Metastatic Malignant Melanoma

Flavopiridol in Treating Patients With Recurrent, Locally Advanced, or Metastatic Soft Tissue Sarcoma

An Expanded Treatment Protocol of Panobinostat in Combination Therapy for Relapsed, and Relapsed and Refractory Multiple Myeloma

Evaluation of Virtual Touch Tissue Imaging Quantification (VTIQ - 2D-SWE) in the Assessment of BI-RADS® 3 and 4 Lesions